p63 immunoreactivity in lung cancer: Yet another player in the development of squamous cell carcinomas?

Journal of Pathology

Volumn 198, Issue 1, 2002, Pages 100-109

  Pelosi, Giuseppe ^a,d   Pasini, Felice ^b   Stenholm, Catharina Olsen ^c   Pastorino, Ugo ^d   Maisonneuve, Patrick ^d   Sonzogni, Angelica ^a   Maffini, Fausto ^a   Pruneri, Giancarlo ^a   Fraggetta, Filippo ^e   Cavallon, Alessandra ^a   Roz, Elena ^a   Iannucci, Antonio ^f   Bresaola, Enrica ^b   Viale, Giuseppe ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c AGILENT TECHNOLOGIES   (United States)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e CANNIZZARO HOSPITAL   (Italy)

^f UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Adenocarcinoma; Immunohistochemistry; Neuroendocrine tumours; Non small cell lung cancer; p63 protein; Prognosis; Squamous cell carcinoma

Indexed keywords

PROTEIN P63; TRANSCRIPTION FACTOR;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CARCINOID; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LARGE CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PRECANCER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FAMILY; REPORTER GENE; SQUAMOUS CELL CARCINOMA; TRANSACTIVATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRONCHI; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0036724213     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1166     Document Type: Article

References (49)

1. A novel protein with strong homology to the tumor suppressor p53
2. A new human p53 homologue
3. A second p53-related protein, p73L, with high homology to p73
4. Mutational analysis of the p63/p73L/p5l/p4O/CUSP/KET gene in human cancer cell lines using intronic primers
5. Cloning and functional analysis of human p5l, which structurally and functionally resembles p53
6. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities
7. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions
8. The emerging p53 gene family
9. Down-regulation of p63 is required for epidermal UV-B- induced apoptosis
10. p63 and p73 trans-activate differentiation gene promoters in human keratinocytes
11. p63 is a prostate basal cell marker and is required for prostate development
12. Mutational analysis of p51A/TAγ63g, a p53 homolog, in non-small cell lung cancer and breast cancer
13. AIS is an oncogene amplified in squamous cell carcinoma
14. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome
15. p63 is a p53 homologue required for limb and epidermal morphogenesis
16. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
17. Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic cells
18. p53 family genes: Structural comparison, expression and mutation
19. Expression of the p53 homologue p63 in early cervical neoplasia
20. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: A study with the p53 homologue p63
21. Stratified mucin-producing intraepithelial lesions of the cervix: Adenosquamous or columnar cell neoplasia?
22. Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27
23. Heterozygous germline missense mutation in the p63 gene underlying EEC syndrome
24. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma
25. High level expression of deltaN-p63: A mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NFC)?
26. Frequent alteration pf p63 expression in human primary bladder carcinomas
27. Characterization of the expression pattern of p63alpha and deltanp63alpha in benign and malignant oral epithelial lesions
28. Mutation and transcription analyses of the p63 gene in cervical carcinoma
29. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes
30. The transcriptional activities of p53 and its homologue p51/p63: Similarities and differences
31. Mutation and expression of the p51 gene in human lung cancer
32. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters
33. Revisions in the international system for staging for lung cancer
34. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid
35. Pulmonary neoplasms
36. CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours
37. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: Use of microwave oven heating to block antibody crossreactivity and retrieve antigens
38. Specificity controls for immunocytochemical methods
39. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with PCNA and progesterone receptor protein immunostaining, mitotic clinicopathologic variables
40. The use of the nitrogen mustards in the palliative treatment of carcinoma: With particular reference to bronchogenic carcinoma
41. Cell kinetics of normal adult hamster bronchial epithelium in the steady state
42. Stem cell in the lung
43. Stem cells in lung development, disease, and therapy
44. Precursors to pulmonary neoplasia
45. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma
46. A broad amplification pattern at 3q in squamous cell lung cancer: A fluorescence in situ hybridization study
47. Atypical adenomatous hyperplasia of the lung: Implications for the pathogenesis of peripheral lung adenocarcinoma
48. Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas